Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
47.24
+1.22 (2.65%)
Nov 22, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 136.52 | 213.58 | 132.94 | 307.58 | 713.53 | 433.58 | Upgrade
|
| Short-Term Investments | 470.99 | 363.63 | 614.82 | 432.61 | 488.01 | 321.65 | Upgrade
|
| Cash & Short-Term Investments | 607.51 | 577.21 | 747.76 | 740.2 | 1,202 | 755.23 | Upgrade
|
| Cash Growth | 37.42% | -22.81% | 1.02% | -38.40% | 59.09% | 64.29% | Upgrade
|
| Accounts Receivable | 93.3 | 73.39 | 40.45 | 28.43 | 23.09 | 32.84 | Upgrade
|
| Other Receivables | 1.8 | 1.1 | 6.4 | 16 | 9.6 | 17.8 | Upgrade
|
| Receivables | 95.1 | 74.49 | 46.85 | 44.43 | 32.69 | 50.64 | Upgrade
|
| Inventory | 43.33 | 33.97 | 26.77 | 16.23 | 13.05 | 11.55 | Upgrade
|
| Prepaid Expenses | - | - | - | 55.75 | 37.18 | 33.44 | Upgrade
|
| Restricted Cash | 20.28 | 2.01 | 0.86 | - | 10.85 | 0.16 | Upgrade
|
| Other Current Assets | 33.39 | 44.51 | 61.66 | - | - | - | Upgrade
|
| Total Current Assets | 799.61 | 732.18 | 883.9 | 856.6 | 1,295 | 851.02 | Upgrade
|
| Property, Plant & Equipment | 272.45 | 314.47 | 285.73 | 176.18 | 114.04 | 74.68 | Upgrade
|
| Long-Term Investments | 203.09 | 199.9 | 148.97 | 293.86 | 165.88 | 32.93 | Upgrade
|
| Goodwill | 44.41 | 44.41 | 44.41 | 44.41 | 44.41 | 44.41 | Upgrade
|
| Other Intangible Assets | 164.94 | 166.27 | 160.11 | 130.79 | 131.11 | 129 | Upgrade
|
| Other Long-Term Assets | 53.87 | 33.79 | 22.34 | 20.56 | 6.71 | 3.47 | Upgrade
|
| Total Assets | 1,538 | 1,491 | 1,545 | 1,522 | 1,760 | 1,135 | Upgrade
|
| Accounts Payable | 35.99 | 42.11 | 43.27 | 17.14 | 12.92 | 12.87 | Upgrade
|
| Accrued Expenses | 185.03 | 196.49 | 204.68 | 145.56 | 108.49 | 83.19 | Upgrade
|
| Current Portion of Long-Term Debt | 48.73 | 29.24 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 10.42 | 12.6 | 11.78 | 11.07 | 8.98 | 7.24 | Upgrade
|
| Current Unearned Revenue | - | - | 1.48 | 7.61 | 59.22 | - | Upgrade
|
| Other Current Liabilities | 4.84 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 285.01 | 280.44 | 261.21 | 181.37 | 189.61 | 103.3 | Upgrade
|
| Long-Term Debt | 829.69 | 862.33 | 875.44 | 351.79 | 335.67 | 315.37 | Upgrade
|
| Long-Term Leases | 23.66 | 30.57 | 19.81 | 30.9 | 39.25 | 29.76 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 1.47 | 7.35 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 30.06 | 30.06 | 31.67 | 33.31 | 33.31 | 33.31 | Upgrade
|
| Other Long-Term Liabilities | 16.13 | 12.21 | 4.82 | 1.01 | - | - | Upgrade
|
| Total Liabilities | 1,185 | 1,216 | 1,193 | 599.84 | 605.18 | 481.73 | Upgrade
|
| Common Stock | 0.09 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 4,169 | 3,662 | 3,140 | 2,997 | 2,773 | 2,087 | Upgrade
|
| Retained Earnings | -3,823 | -3,388 | -2,781 | -2,074 | -1,620 | -1,433 | Upgrade
|
| Treasury Stock | -3.56 | -0.43 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 4.45 | 1.08 | -6.57 | -1.4 | 0.69 | -0.15 | Upgrade
|
| Total Common Equity | 346.83 | 275.41 | 352.49 | 922.56 | 1,154 | 653.76 | Upgrade
|
| Shareholders' Equity | 353.83 | 275.41 | 352.49 | 922.56 | 1,154 | 653.76 | Upgrade
|
| Total Liabilities & Equity | 1,538 | 1,491 | 1,545 | 1,522 | 1,760 | 1,135 | Upgrade
|
| Total Debt | 912.5 | 934.74 | 907.03 | 393.76 | 383.89 | 352.36 | Upgrade
|
| Net Cash (Debt) | -101.9 | -157.63 | -10.3 | 605.37 | 828.15 | 408.04 | Upgrade
|
| Net Cash Growth | - | - | - | -26.90% | 102.96% | -11.24% | Upgrade
|
| Net Cash Per Share | -1.17 | -2.14 | -0.15 | 8.93 | 13.61 | 7.21 | Upgrade
|
| Filing Date Shares Outstanding | 92.28 | 82.34 | 70.22 | 69.38 | 66.95 | 57.89 | Upgrade
|
| Total Common Shares Outstanding | 92.24 | 82.32 | 70.2 | 69.34 | 66.82 | 57.84 | Upgrade
|
| Working Capital | 514.6 | 451.75 | 622.69 | 675.24 | 1,106 | 747.72 | Upgrade
|
| Book Value Per Share | 3.76 | 3.35 | 5.02 | 13.30 | 17.28 | 11.30 | Upgrade
|
| Tangible Book Value | 137.48 | 64.74 | 147.98 | 747.37 | 978.86 | 480.36 | Upgrade
|
| Tangible Book Value Per Share | 1.49 | 0.79 | 2.11 | 10.78 | 14.65 | 8.31 | Upgrade
|
| Land | - | 16.62 | 16.62 | 15.49 | 11.72 | - | Upgrade
|
| Buildings | - | 181.36 | 2.8 | - | - | - | Upgrade
|
| Machinery | - | 116.26 | 70.28 | 54.31 | 41.63 | 29.19 | Upgrade
|
| Construction In Progress | - | 0.87 | 189.45 | 76.85 | 17.65 | 24.27 | Upgrade
|
| Leasehold Improvements | - | 58.68 | 43.94 | 44.08 | 39.36 | 16.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.